https://www.selleckchem.com/products/dtnb.html
8% of those with SHL (21 of 34) and 41.3% of those without SHL (43 of 104) (p = 0.048. On univariate and multivariate analysis (accounting for tumor size and preoperative hearing quality), SHL was a significant positive predictor of HP (odds ratio 2.292, p = 0.0407 and odds ratio 2.778, p = 0.0032, respectively). In patients with VS and retained serviceable hearing, SHL is an independent predictor of HP after retrosigmoid microsurgical resection when the cochlear nerve is preserved. In patients with VS and retained serviceable hearing, S
Like
Comment
Share
